Lifecore Biomedical Ownership 2024 | Who Owns Lifecore Biomedical Now?
Institutional Ownership
74.79%
Insider Ownership
5.82%
Retail Ownership
19.39%
Institutional Holders
80.00
Lifecore Biomedical Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC | 16.61% | 12.04% | 4,923,545 | 461,035 | 10.33% | 18,586,382,000 | Mar 31, 2023 |
| LEGION PARTNERS ASSET MANAGEMENT, LLC | 9.92% | 3.27% | 2,940,340 | - | - | 11,114,485,000 | Mar 31, 2023 |
| BLACKROCK INC. | 6.41% | 0.00% | 1,898,495 | 50,342 | 2.72% | 7,166,819,000 | Mar 31, 2023 |
| COVE STREET CAPITAL, LLC | 6.36% | 2.12% | 1,884,344 | -61,850 | -3.18% | 7,114,000 | Mar 31, 2023 |
| 22NW, LP | 5.92% | 4.08% | 1,755,161 | - | - | 6,634,509,000 | Mar 31, 2023 |
| VANGUARD GROUP INC | 4.94% | 0.00% | 1,464,684 | 190,815 | 14.98% | 5,529,182,000 | Mar 31, 2023 |
| GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P. | 3.49% | 2.24% | 1,034,449 | 1,034,449 | 100.00% | 39,050,000 | Mar 31, 2023 |
| MORGAN STANLEY | 2.93% | 0.00% | 869,100 | 229,501 | 35.88% | 3,280,853,000 | Mar 31, 2023 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 1.84% | 0.04% | 545,200 | -13,300 | -2.38% | 2,058,130,000 | Mar 31, 2023 |
| VISIONARY WEALTH ADVISORS | 1.69% | 0.16% | 500,269 | -1,450 | -0.29% | 1,888,516,000 | Mar 31, 2023 |
| HEARTLAND ADVISORS INC | 1.69% | 0.12% | 500,000 | -701,900 | -58.40% | 1,887,500,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.66% | 0.00% | 492,390 | 27,175 | 5.84% | 1,858,772,000 | Mar 31, 2023 |
| STATE STREET CORP | 1.65% | 0.00% | 489,198 | 44 | 0.01% | 1,846,722,000 | Mar 31, 2023 |
| ANSON FUNDS MANAGEMENT LP | 1.60% | 0.30% | 475,062 | 475,062 | 100.00% | 1,793,359,000,000,000 | Mar 31, 2023 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.81% | 0.00% | 238,836 | - | - | 901,603,000 | Mar 31, 2023 |
| NORTHERN TRUST CORP | 0.77% | 0.00% | 227,790 | 218 | 0.10% | 859,907,000 | Mar 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.66% | 0.06% | 194,700 | 194,700 | 100.00% | 734,992,000 | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | 0.58% | 0.00% | 171,451 | 56,300 | 48.89% | 647,000 | Mar 31, 2023 |
| IRENIC CAPITAL MANAGEMENT LP | 0.52% | 0.20% | 155,465 | 155,465 | 100.00% | 586,880,000 | Mar 31, 2023 |
| ROYAL BANK OF CANADA | 0.50% | 0.00% | 148,467 | -2,228 | -1.48% | 561,000,000 | Mar 31, 2023 |
Lifecore Biomedical's largest institutional shareholder is WYNNEFIELD CAPITAL INC, holding 16.61% of the company's total share outstanding, currently valued at $18.59B. The top 10 institutional shareholders own together 60.12% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC | 16.61% | 12.04% | 4,923,545 | 461,035 | 10.33% | 18,586,382,000 | Mar 31, 2023 |
| 22NW, LP | 5.92% | 4.08% | 1,755,161 | - | - | 6,634,509,000 | Mar 31, 2023 |
| LEGION PARTNERS ASSET MANAGEMENT, LLC | 9.92% | 3.27% | 2,940,340 | - | - | 11,114,485,000 | Mar 31, 2023 |
| GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P. | 3.49% | 2.24% | 1,034,449 | 1,034,449 | 100.00% | 39,050,000 | Mar 31, 2023 |
| COVE STREET CAPITAL, LLC | 6.36% | 2.12% | 1,884,344 | -61,850 | -3.18% | 7,114,000 | Mar 31, 2023 |
| COVE STREET CAPITAL, LLC | 0.01% | 0.53% | 3,000 | 3,000 | 100.00% | 1,783,000 | Mar 31, 2023 |
| ANSON FUNDS MANAGEMENT LP | 1.60% | 0.30% | 475,062 | 475,062 | 100.00% | 1,793,359,000,000,000 | Mar 31, 2023 |
| IRENIC CAPITAL MANAGEMENT LP | 0.52% | 0.20% | 155,465 | 155,465 | 100.00% | 586,880,000 | Mar 31, 2023 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 0.42% | 0.18% | 124,928 | 124,928 | 100.00% | 471,603,000 | Mar 31, 2023 |
| VISIONARY WEALTH ADVISORS | 1.69% | 0.16% | 500,269 | -1,450 | -0.29% | 1,888,516,000 | Mar 31, 2023 |
| DIAMETRIC CAPITAL, LP | 0.22% | 0.12% | 64,920 | 64,920 | 100.00% | 245,073,000 | Mar 31, 2023 |
| HEARTLAND ADVISORS INC | 1.69% | 0.12% | 500,000 | -701,900 | -58.40% | 1,887,500,000 | Mar 31, 2023 |
| DEFENDER CAPITAL, LLC. | 0.29% | 0.11% | 86,450 | - | - | 326,349,000,000,000 | Mar 31, 2023 |
| KEENE & ASSOCIATES, INC. | 0.08% | 0.07% | 24,100 | 10,700 | 79.85% | 90,978,000 | Mar 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.66% | 0.06% | 194,700 | 194,700 | 100.00% | 734,992,000 | Mar 31, 2023 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 1.84% | 0.04% | 545,200 | -13,300 | -2.38% | 2,058,130,000 | Mar 31, 2023 |
| CUTTER & CO BROKERAGE, INC. | 0.07% | 0.03% | 21,700 | - | - | 81,918,000 | Mar 31, 2023 |
| PINNACLE WEALTH PLANNING SERVICES, INC. | 0.06% | 0.01% | 19,025 | 19,025 | 100.00% | 71,819,000 | Mar 31, 2023 |
| COVESTOR LTD | 0.01% | 0.01% | 2,839 | 2,839 | 100.00% | 11,000 | Mar 31, 2023 |
| DIVERSIFIED TRUST CO | 0.16% | 0.01% | 46,062 | - | - | 173,884,000 | Mar 31, 2023 |
The largest Lifecore Biomedical shareholder by % of total assets is WYNNEFIELD CAPITAL INC. The company owns 4.92M shares of Lifecore Biomedical (LFCR), representing 12.04% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P. | 3.49% | 2.24% | 1,034,449 | 1,034,449 | 100.00% | 39,050,000 | Mar 31, 2023 |
| ANSON FUNDS MANAGEMENT LP | 1.60% | 0.30% | 475,062 | 475,062 | 100.00% | 1,793,359,000,000,000 | Mar 31, 2023 |
| WYNNEFIELD CAPITAL INC | 16.61% | 12.04% | 4,923,545 | 461,035 | 10.33% | 18,586,382,000 | Mar 31, 2023 |
| MORGAN STANLEY | 2.93% | 0.00% | 869,100 | 229,501 | 35.88% | 3,280,853,000 | Mar 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.66% | 0.06% | 194,700 | 194,700 | 100.00% | 734,992,000 | Mar 31, 2023 |
| VANGUARD GROUP INC | 4.94% | 0.00% | 1,464,684 | 190,815 | 14.98% | 5,529,182,000 | Mar 31, 2023 |
| IRENIC CAPITAL MANAGEMENT LP | 0.52% | 0.20% | 155,465 | 155,465 | 100.00% | 586,880,000 | Mar 31, 2023 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 0.42% | 0.18% | 124,928 | 124,928 | 100.00% | 471,603,000 | Mar 31, 2023 |
| DIAMETRIC CAPITAL, LP | 0.22% | 0.12% | 64,920 | 64,920 | 100.00% | 245,073,000 | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | 0.58% | 0.00% | 171,451 | 56,300 | 48.89% | 647,000 | Mar 31, 2023 |
| BLACKROCK INC. | 6.41% | 0.00% | 1,898,495 | 50,342 | 2.72% | 7,166,819,000 | Mar 31, 2023 |
| BELVEDERE TRADING LLC | 0.14% | 0.00% | 41,176 | 41,176 | 100.00% | 155,439,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 0.17% | 0.00% | 49,401 | 38,527 | 354.30% | 186,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.18% | - | 52,912 | 34,585 | 188.71% | 199,743,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.66% | 0.00% | 492,390 | 27,175 | 5.84% | 1,858,772,000 | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.09% | - | 25,500 | 22,300 | 696.88% | 96,263,000 | Mar 31, 2023 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.07% | 0.00% | 21,295 | 21,295 | 100.00% | 80,389,000 | Mar 31, 2023 |
| PINNACLE WEALTH PLANNING SERVICES, INC. | 0.06% | 0.01% | 19,025 | 19,025 | 100.00% | 71,819,000 | Mar 31, 2023 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.06% | 0.00% | 17,700 | 17,700 | 100.00% | 66,818,000 | Mar 31, 2023 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.06% | 0.00% | 17,370 | 17,370 | 100.00% | 65,572,000 | Mar 31, 2023 |
As of Mar 31 2023, Lifecore Biomedical's largest institutional buyer is GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P.. The company purchased 1.03M stocks of LFCR, valued at $39.05M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | 0.13% | - | 38,897 | -1,718,647 | -97.79% | 146,836,000 | Mar 31, 2023 |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | - | - | - | -776,460 | -100.00% | - | Mar 31, 2023 |
| HEARTLAND ADVISORS INC | 1.69% | 0.12% | 500,000 | -701,900 | -58.40% | 1,887,500,000 | Mar 31, 2023 |
| PACIFIC RIDGE CAPITAL PARTNERS, LLC | - | - | - | -416,861 | -100.00% | - | Mar 31, 2023 |
| ISZO CAPITAL MANAGEMENT LP | - | - | - | -373,778 | -100.00% | - | Mar 31, 2023 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -203,578 | -100.00% | - | Mar 31, 2023 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -167,115 | -100.00% | - | Mar 31, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -141,446 | -100.00% | - | Mar 31, 2023 |
| INVESCO LTD. | - | - | - | -95,475 | -100.00% | - | Mar 31, 2023 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -90,357 | -100.00% | - | Mar 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -83,755 | -100.00% | - | Mar 31, 2023 |
| ANCORA ADVISORS, LLC | - | - | - | -77,551 | -100.00% | - | Mar 31, 2023 |
| LEWIS CAPITAL MANAGEMENT, LLC | - | - | - | -74,823 | -100.00% | - | Mar 31, 2023 |
| COVE STREET CAPITAL, LLC | 6.36% | 2.12% | 1,884,344 | -61,850 | -3.18% | 7,114,000 | Mar 31, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -55,000 | -100.00% | - | Mar 31, 2023 |
| D. E. SHAW & CO., INC. | - | - | - | -47,971 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -40,036 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 3,885 | -30,521 | -88.71% | 15,000 | Mar 31, 2023 |
| MARTINGALE ASSET MANAGEMENT L P | - | - | - | -24,430 | -100.00% | - | Mar 31, 2023 |
| RIVERWATER PARTNERS LLC | - | - | - | -20,616 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Lifecore Biomedical's biggest institutional seller is DIMENSIONAL FUND ADVISORS LP. The company sold -1.72M shares of LFCR, valued at $146.84M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P. | 3.49% | 2.24% | 1,034,449 | 1,034,449 | 100.00% | 39,050,000 | Mar 31, 2023 |
| ANSON FUNDS MANAGEMENT LP | 1.60% | 0.30% | 475,062 | 475,062 | 100.00% | 1,793,359,000,000,000 | Mar 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.66% | 0.06% | 194,700 | 194,700 | 100.00% | 734,992,000 | Mar 31, 2023 |
| IRENIC CAPITAL MANAGEMENT LP | 0.52% | 0.20% | 155,465 | 155,465 | 100.00% | 586,880,000 | Mar 31, 2023 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 0.42% | 0.18% | 124,928 | 124,928 | 100.00% | 471,603,000 | Mar 31, 2023 |
| DIAMETRIC CAPITAL, LP | 0.22% | 0.12% | 64,920 | 64,920 | 100.00% | 245,073,000 | Mar 31, 2023 |
| BELVEDERE TRADING LLC | 0.14% | 0.00% | 41,176 | 41,176 | 100.00% | 155,439,000 | Mar 31, 2023 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.07% | 0.00% | 21,295 | 21,295 | 100.00% | 80,389,000 | Mar 31, 2023 |
| PINNACLE WEALTH PLANNING SERVICES, INC. | 0.06% | 0.01% | 19,025 | 19,025 | 100.00% | 71,819,000 | Mar 31, 2023 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.06% | 0.00% | 17,700 | 17,700 | 100.00% | 66,818,000 | Mar 31, 2023 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.06% | 0.00% | 17,370 | 17,370 | 100.00% | 65,572,000 | Mar 31, 2023 |
| SMITH, MOORE & CO. | 0.04% | 0.01% | 12,000 | 12,000 | 100.00% | 45,300,000 | Mar 31, 2023 |
| COVE STREET CAPITAL, LLC | 0.01% | 0.53% | 3,000 | 3,000 | 100.00% | 1,783,000 | Mar 31, 2023 |
| COVESTOR LTD | 0.01% | 0.01% | 2,839 | 2,839 | 100.00% | 11,000 | Mar 31, 2023 |
| QUADRANT CAPITAL GROUP LLC | 0.01% | 0.00% | 2,416 | 2,416 | 100.00% | 9,121,000 | Mar 31, 2023 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | 0.00% | 499 | 499 | 100.00% | 2,196,000 | Mar 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 409 | 409 | 100.00% | 1,544,000 | Mar 31, 2023 |
| MASSMUTUAL TRUST CO FSB/ADV | 0.00% | - | 51 | 51 | 100.00% | 193,000 | Mar 31, 2023 |
Lifecore Biomedical's largest new institutional shareholder by number of shares is GREENHAVEN ROAD INVESTMENT MANAGEMENT, L.P., purchased 1.03M shares, valued at $39.05M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | - | - | - | -776,460 | -100.00% | - | Mar 31, 2023 |
| PACIFIC RIDGE CAPITAL PARTNERS, LLC | - | - | - | -416,861 | -100.00% | - | Mar 31, 2023 |
| ISZO CAPITAL MANAGEMENT LP | - | - | - | -373,778 | -100.00% | - | Mar 31, 2023 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -203,578 | -100.00% | - | Mar 31, 2023 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -167,115 | -100.00% | - | Mar 31, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -141,446 | -100.00% | - | Mar 31, 2023 |
| INVESCO LTD. | - | - | - | -95,475 | -100.00% | - | Mar 31, 2023 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -90,357 | -100.00% | - | Mar 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -83,755 | -100.00% | - | Mar 31, 2023 |
| ANCORA ADVISORS, LLC | - | - | - | -77,551 | -100.00% | - | Mar 31, 2023 |
| LEWIS CAPITAL MANAGEMENT, LLC | - | - | - | -74,823 | -100.00% | - | Mar 31, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -55,000 | -100.00% | - | Mar 31, 2023 |
| D. E. SHAW & CO., INC. | - | - | - | -47,971 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -40,036 | -100.00% | - | Mar 31, 2023 |
| MARTINGALE ASSET MANAGEMENT L P | - | - | - | -24,430 | -100.00% | - | Mar 31, 2023 |
| RIVERWATER PARTNERS LLC | - | - | - | -20,616 | -100.00% | - | Mar 31, 2023 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -19,966 | -100.00% | - | Mar 31, 2023 |
| SQUAREPOINT OPS LLC | - | - | - | -17,789 | -100.00% | - | Mar 31, 2023 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -15,354 | -100.00% | - | Mar 31, 2023 |
| ALGERT GLOBAL LLC | - | - | - | -12,206 | -100.00% | - | Mar 31, 2023 |
| JUMP FINANCIAL, LLC | - | - | - | -12,200 | -100.00% | - | Mar 31, 2023 |
| BARCLAYS PLC | - | - | - | -8,184 | -100.00% | - | Mar 31, 2023 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | - | - | - | -7,115 | -100.00% | - | Mar 31, 2023 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -5,613 | -100.00% | - | Mar 31, 2023 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -3,630 | -100.00% | - | Mar 31, 2023 |
| POINT72 MIDDLE EAST FZE | - | - | - | -930 | -100.00% | - | Mar 31, 2023 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -900 | -100.00% | - | Mar 31, 2023 |
| ELLEVEST, INC. | - | - | - | -294 | -100.00% | - | Mar 31, 2023 |
| CREDIT SUISSE AG/ | - | - | - | -1 | -100.00% | - | Mar 31, 2023 |
Lifecore Biomedical's largest sold out institutional shareholder by shares sold is PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., sold -0.78M shares, valued at -, as of undefined.
Lifecore Biomedical Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Managed Portfolio Series | 0.01% | 210,000 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 150 | - | - | Jan 31, 2024 |
Lifecore Biomedical's largest mutual fund holder by % of total assets is "Managed Portfolio Series", owning 210.00K shares, compromising 0.01% of its total assets.
Lifecore Biomedical Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 23 | 80 | -13.04% |
| 31 Dec, 22 | 92 | 2966.67% |
| 30 Sep, 22 | 3 | 50.00% |
| 30 Jun, 22 | 2 | - |
| 31 Mar, 22 | 2 | - |
| 31 Dec, 21 | 2 | - |
| 30 Sep, 21 | 2 | - |
| 31 Mar, 21 | - | -100.00% |
| 31 Dec, 20 | 2 | - |
| 30 Sep, 20 | 2 | - |
| 30 Jun, 20 | 2 | - |
| 31 Mar, 20 | 2 | - |
| 31 Dec, 19 | 2 | - |
| 30 Sep, 19 | 2 | - |
| 30 Jun, 19 | 2 | 100.00% |
| 31 Mar, 19 | 1 | - |
| 30 Sep, 18 | 1 | - |
As of 31 Mar 23, 80 institutions are holding Lifecore Biomedical's shares, representing a decrease of -13.04% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 23 | 22,664,178 | -8.20% |
| 31 Dec, 22 | 24,688,264 | 88786.64% |
| 30 Sep, 22 | 27,775 | 104.94% |
| 30 Jun, 22 | 13,553 | -18.96% |
| 31 Mar, 22 | 16,724 | 97.71% |
| 31 Dec, 21 | 8,459 | -51.81% |
| 30 Sep, 21 | 17,555 | - |
| 31 Mar, 21 | - | -100.00% |
| 31 Dec, 20 | 20,220 | 28.14% |
| 30 Sep, 20 | 15,780 | -23.79% |
| 30 Jun, 20 | 20,705 | - |
| 31 Mar, 20 | 20,705 | 5.59% |
| 31 Dec, 19 | 19,608 | 92.59% |
| 30 Sep, 19 | 10,181 | -56.77% |
| 30 Jun, 19 | 23,553 | 68.12% |
| 31 Mar, 19 | 14,010 | -35.49% |
| 30 Sep, 18 | 21,719 | - |
Lifecore Biomedical (LFCR) has 22.66M shares outstanding as of 31 Mar 23, down -8.20% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 23 | 74.79% | -10.23% |
| 31 Dec, 22 | 83.31% | 88622.68% |
| 30 Sep, 22 | 0.09% | 104.13% |
| 30 Jun, 22 | 0.05% | -18.87% |
| 31 Mar, 22 | 0.06% | 97.56% |
| 31 Dec, 21 | 0.03% | -51.93% |
| 30 Sep, 21 | 0.06% | - |
| 31 Mar, 21 | - | -100.00% |
| 31 Dec, 20 | 0.07% | 27.96% |
| 30 Sep, 20 | 0.05% | -23.94% |
| 30 Jun, 20 | 0.07% | - |
| 31 Mar, 20 | 0.07% | 5.50% |
| 31 Dec, 19 | 0.07% | 92.55% |
| 30 Sep, 19 | 0.03% | -57.59% |
| 30 Jun, 19 | 0.08% | 71.31% |
| 31 Mar, 19 | 0.05% | -38.06% |
| 30 Sep, 18 | 0.08% | - |
As of 31 Mar 23, Lifecore Biomedical is held by 74.79% institutional shareholders, representing a -10.23% negative growth compared to 31 Dec 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 26 | -66.67% |
| 31 Dec, 22 | 78 | 3800.00% |
| 30 Sep, 22 | 2 | - |
| 30 Jun, 22 | - | -100.00% |
| 31 Mar, 22 | 1 | - |
| 31 Dec, 21 | - | - |
| 30 Sep, 21 | - | - |
| 31 Mar, 21 | - | -100.00% |
| 31 Dec, 20 | 2 | - |
| 30 Sep, 20 | - | - |
| 30 Jun, 20 | - | -100.00% |
| 31 Mar, 20 | 1 | -50.00% |
| 31 Dec, 19 | 2 | - |
| 30 Sep, 19 | - | -100.00% |
| 30 Jun, 19 | 1 | - |
| 31 Mar, 19 | - | -100.00% |
| 30 Sep, 18 | 1 | - |
26 institutional shareholders have increased their position in LFCR stock as of 31 Mar 23 compared to 78 in the previous quarter (a -66.67% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 17 | - |
| 31 Dec, 22 | - | - |
| 30 Sep, 22 | - | -100.00% |
| 30 Jun, 22 | 1 | - |
| 31 Mar, 22 | 1 | -50.00% |
| 31 Dec, 21 | 2 | - |
| 30 Sep, 21 | - | - |
| 31 Mar, 21 | - | - |
| 31 Dec, 20 | - | -100.00% |
| 30 Sep, 20 | 1 | - |
| 30 Jun, 20 | - | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | -100.00% |
| 30 Sep, 19 | 2 | - |
| 30 Jun, 19 | - | -100.00% |
| 31 Mar, 19 | 1 | - |
| 30 Sep, 18 | - | - |
17 institutional shareholders have reduced their position in LFCR stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 23 | 80 | -13.04% | 22,664,178 | -8.20% | 74.79% | -10.23% | 26 | -66.67% | 17 | - |
| 31 Dec, 22 | 92 | 2966.67% | 24,688,264 | 88786.64% | 83.31% | 88622.68% | 78 | 3800.00% | - | - |
| 30 Sep, 22 | 3 | 50.00% | 27,775 | 104.94% | 0.09% | 104.13% | 2 | - | - | -100.00% |
| 30 Jun, 22 | 2 | - | 13,553 | -18.96% | 0.05% | -18.87% | - | -100.00% | 1 | - |
| 31 Mar, 22 | 2 | - | 16,724 | 97.71% | 0.06% | 97.56% | 1 | - | 1 | -50.00% |
| 31 Dec, 21 | 2 | - | 8,459 | -51.81% | 0.03% | -51.93% | - | - | 2 | - |
| 30 Sep, 21 | 2 | - | 17,555 | - | 0.06% | - | - | - | - | - |
| 31 Mar, 21 | - | -100.00% | - | -100.00% | - | -100.00% | - | -100.00% | - | - |
| 31 Dec, 20 | 2 | - | 20,220 | 28.14% | 0.07% | 27.96% | 2 | - | - | -100.00% |
| 30 Sep, 20 | 2 | - | 15,780 | -23.79% | 0.05% | -23.94% | - | - | 1 | - |
| 30 Jun, 20 | 2 | - | 20,705 | - | 0.07% | - | - | -100.00% | - | - |
| 31 Mar, 20 | 2 | - | 20,705 | 5.59% | 0.07% | 5.50% | 1 | -50.00% | - | - |
| 31 Dec, 19 | 2 | - | 19,608 | 92.59% | 0.07% | 92.55% | 2 | - | - | -100.00% |
| 30 Sep, 19 | 2 | - | 10,181 | -56.77% | 0.03% | -57.59% | - | -100.00% | 2 | - |
| 30 Jun, 19 | 2 | 100.00% | 23,553 | 68.12% | 0.08% | 71.31% | 1 | - | - | -100.00% |
| 31 Mar, 19 | 1 | - | 14,010 | -35.49% | 0.05% | -38.06% | - | -100.00% | 1 | - |
| 30 Sep, 18 | 1 | - | 21,719 | - | 0.08% | - | 1 | - | - | - |
Lifecore Biomedical Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Lifecore Biomedical's stock was made by Josephs Paul on May 22 2024, selling 8,975 shares at - per share (valued at -).
Lifecore Biomedical Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 8 | - | - |
| Q2 2024 | 2 | 2 | 100.00% |
| Q1 2024 | 9 | 10 | 90.00% |
| Q2 2023 | 18 | 6 | 300.00% |
| Q1 2023 | 17 | 2 | 850.00% |
| Q4 2022 | 2 | - | - |
8 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Lifecore Biomedical's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | 6 | - | - |
| Q4 2022 | 2 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Lifecore Biomedical's stocks.
Lifecore Biomedical Peer Ownership
| Ticker | Company |
|---|---|
| AKAN | Akanda Corp. |
| TLRY | Tilray Brands, Inc. |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| ALIM | Alimera Sciences, Inc. |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. |
| DERM | Journey Medical Corporation |
| CPIX | Cumberland Pharmaceuticals Inc. |
| ADMP | Adamis Pharmaceuticals Corporation |
| LSDI | Lucy Scientific Discovery Inc. |
| KMDA | Kamada Ltd. |
| CTLT | Catalent, Inc. |
LFCR Ownership FAQ
Who Owns Lifecore Biomedical?
Lifecore Biomedical is owned by institutional shareholders (74.79%), insiders (5.82%), and public (19.39%). The largest institutional shareholder of Lifecore Biomedical is WYNNEFIELD CAPITAL INC (16.61% of total shares) and the top mutual fund owner is Managed Portfolio Series (0.01% of total shares).
Who are the major institutional shareholders of Lifecore Biomedical?
Lifecore Biomedical's major institutional shareholders are WYNNEFIELD CAPITAL INC, LEGION PARTNERS ASSET MANAGEMENT, LLC, BLACKROCK INC., COVE STREET CAPITAL, LLC, and 22NW, LP. The top five shareholders own together 45.22% of the company's share outstanding.
How many Lifecore Biomedical shareholders are there?
As of Mar 2023, there are 80 institutional shareholders of Lifecore Biomedical.
What percentage of Lifecore Biomedical is owned by WYNNEFIELD CAPITAL INC?
WYNNEFIELD CAPITAL INC owns 4.92M shares of Lifecore Biomedical, representing 16.61% of the company's total shares outstanding, valued at $18.59B (as of Mar 2023).
What percentage of Lifecore Biomedical is owned by LEGION PARTNERS ASSET MANAGEMENT, LLC?
As of Mar 2023, LEGION PARTNERS ASSET MANAGEMENT, LLC holds 2.94M shares of Lifecore Biomedical (LFCR), compromising 9.92% of the company, valued at $11.11B.
What percentage of Lifecore Biomedical is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Lifecore Biomedical. The company owns 1.9M of the company's shares outstanding (worth $7.17B).